ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ZNTL Zentalis Pharmaceuticals Inc

3.00
0.07 (2.39%)
21 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Zentalis Pharmaceuticals Inc NASDAQ:ZNTL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 2.39% 3.00 2.92 4.30 3.10 2.89 2.90 1,854,042 05:00:12

Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL

19/08/2024 9:55pm

Business Wire


Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Historical Stock Chart


From Jun 2024 to Dec 2024

Click Here for more Zentalis Pharmaceuticals Charts.

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Zentalis Pharmaceuticals, Inc. (“Zentalis” or the “Company”) (NASDAQ:ZNTL) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”).

Zentalis, headquartered in San Diego, CA, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Newman Ferrara’s investigation focuses on decisions made by the Board, without shareholder approval, the result of which significantly diminish shareholder value and do not benefit the Company. Considering the Company’s lackluster performance since 2020, it is clear that the Board lacks the ability to fairly assess and oversee the Company’s direction and leadership.

Current Zentalis stockholders seeking more information on this matter are invited to contact Newman Ferrara attorneys Jeffrey Norton (jnorton@nfllp.com) or Benjamin Baker (bbaker@nfllp.com) to discuss this investigation and their rights.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.

Newman Ferrara LLP Benjamin Baker bbaker@nfllp.com 1250 Broadway, 27th Fl. New York, NY 10001 (212) 619-5400

1 Year Zentalis Pharmaceuticals Chart

1 Year Zentalis Pharmaceuticals Chart

1 Month Zentalis Pharmaceuticals Chart

1 Month Zentalis Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock